Gene · 498
Papers1,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide screening identifies cell-cycle control as a synthetic lethal pathway with SRSF2P95H mutation. | Blood Adv | 2022 | 34464972 | PubTator, text mining | PubMed |
| Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury. | Cell Biol Toxicol | 2022 | 34401974 | PubTator, text mining | PubMed |
| Mast cell surfaceome characterization reveals CD98 heavy chain is critical for optimal cell function. | J Allergy Clin Immunol | 2022 | 34324892 | PubTator, text mining | PubMed |
| Fourier-transform ion cyclotron resonance mass spectrometry for characterizing proteoforms. | Mass Spectrom Rev | 2022 | 32894796 | PubTator, text mining | PubMed |
| Parents living with a child afflicted by a life-limiting medical condition: Typology of their narrative identity. | Qual Res Med Healthc | 2021 | 37441669 | PubTator, text mining | PubMed |
| A Compound Heterozygous Mutation in Calpain 1 Identifies a New Genetic Cause for Spinal Muscular Atrophy Type 4 (SMA4). | Front Genet | 2021 | 35126465 | PubTator, text mining | PubMed |
| The Metabolism Reprogramming of microRNA Let-7-Mediated Glycolysis Contributes to Autophagy and Tumor Progression. | Int J Mol Sci | 2021 | 35008539 | PubTator, text mining | PubMed |
| Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease. | Front Pharmacol | 2021 | 35002729 | PubTator, text mining | PubMed |
| Characterization of Host Cell Potential Proteins Interacting with OsHV-1 Membrane Proteins. | Viruses | 2021 | 34960787 | PubTator, text mining | PubMed |
| Oxidative Stress Induces Mitochondrial Compromise in CD4 T Cells From Chronically HCV-Infected Individuals. | Front Immunol | 2021 | 34956192 | PubTator, text mining | PubMed |
| Parkin beyond Parkinson's Disease-A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies. | Cells | 2021 | 34943897 | PubTator, text mining | PubMed |
| Dietary Phytoestrogens and Their Metabolites as Epigenetic Modulators with Impact on Human Health. | Antioxidants (Basel) | 2021 | 34942997 | PubTator, text mining | PubMed |
| The decrotonylase FoSir5 facilitates mitochondrial metabolic state switching in conidial germination of Fusarium oxysporum. | Elife | 2021 | 34927582 | PubTator, text mining | PubMed |
| Taxon-Specific Shifts in Bacterial and Archaeal Transcription of Dissolved Organic Matter Cycling Genes in a Stratified Fjord. | mSystems | 2021 | 34904860 | PubTator, text mining | PubMed |
| Mitochondria Dysfunction in Frontotemporal Dementia/Amyotrophic Lateral Sclerosis: Lessons From Drosophila Models. | Front Neurosci | 2021 | 34899176 | PubTator, text mining | PubMed |
| Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer. | Cancers (Basel) | 2021 | 34885151 | PubTator, text mining | PubMed |
| Impact of Hydrogen Sulfide on Mitochondrial and Bacterial Bioenergetics. | Int J Mol Sci | 2021 | 34884491 | PubTator, text mining | PubMed |
| MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure. | Front Cardiovasc Med | 2021 | 34869689 | PubTator, text mining | PubMed |
| High-intensity training induces non-stoichiometric changes in the mitochondrial proteome of human skeletal muscle without reorganisation of respiratory chain content. | Nat Commun | 2021 | 34862379 | PubTator, text mining | PubMed |
| Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium. | J Transl Med | 2021 | 34861865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/498/papers?page=20